Next Article in Journal
Ca2+-ATPase Molecules as a Calcium-Sensitive Membrane-Endoskeleton of Sarcoplasmic Reticulum
Next Article in Special Issue
New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases
Previous Article in Journal
5-Hydroxytryptamine Modulates Maturation and Mitochondria Function of Human Oligodendrocyte Progenitor M03-13 Cells
Previous Article in Special Issue
Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Drug Discovery in Liver Disease Using Kinome Profiling

Department of Gastroenterology and Hepatology, Erasmus MC—University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2021, 22(5), 2623; https://doi.org/10.3390/ijms22052623
Submission received: 20 January 2021 / Revised: 1 March 2021 / Accepted: 1 March 2021 / Published: 5 March 2021
(This article belongs to the Special Issue Advances in Kinase Drug Discovery)

Abstract

The liver is one of the most important organs, playing critical roles in maintaining biochemical homeostasis. Accordingly, disease of the liver is often debilitating and responsible for untold human misery. As biochemical nexus, with kinases being master regulators of cellular biochemistry, targeting kinase enzymes is an obvious avenue for treating liver disease. Development of such therapy, however, is hampered by the technical difficulty of obtaining comprehensive insight into hepatic kinase activity, a problem further compounded by the often unique aspects of hepatic kinase activities, which makes extrapolations from other systems difficult. This consideration prompted us to review the current state of the art with respect to kinome profiling approaches towards the hepatic kinome. We observe that currently four different approaches are available, all showing significant promise. Hence we postulate that insight into the hepatic kinome will quickly increase, leading to rational kinase-targeted therapy for different liver diseases.
Keywords: kinases; kinome; liver; hepatocytes; hepatitis; hepatocellular carcinoma; peptide arrays kinases; kinome; liver; hepatocytes; hepatitis; hepatocellular carcinoma; peptide arrays

Share and Cite

MDPI and ACS Style

Yu, B.; Mamedov, R.; Fuhler, G.M.; Peppelenbosch, M.P. Drug Discovery in Liver Disease Using Kinome Profiling. Int. J. Mol. Sci. 2021, 22, 2623. https://doi.org/10.3390/ijms22052623

AMA Style

Yu B, Mamedov R, Fuhler GM, Peppelenbosch MP. Drug Discovery in Liver Disease Using Kinome Profiling. International Journal of Molecular Sciences. 2021; 22(5):2623. https://doi.org/10.3390/ijms22052623

Chicago/Turabian Style

Yu, Bingting, Ruslan Mamedov, Gwenny M. Fuhler, and Maikel P. Peppelenbosch. 2021. "Drug Discovery in Liver Disease Using Kinome Profiling" International Journal of Molecular Sciences 22, no. 5: 2623. https://doi.org/10.3390/ijms22052623

APA Style

Yu, B., Mamedov, R., Fuhler, G. M., & Peppelenbosch, M. P. (2021). Drug Discovery in Liver Disease Using Kinome Profiling. International Journal of Molecular Sciences, 22(5), 2623. https://doi.org/10.3390/ijms22052623

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop